Limit your answers to a maximum of two sentences for each part.
a) The OSP-C is a lipoprotein known as an antiphagocytic factor. This means the pathogen disrupts phagocytosis
b) Each treatment address the pathogenicity of B. burdorgferi in different states of OSP-C factor:
Wild type: Just how a regular strain would work in mice, it works as a control treatment
OSP-C negative: The main treatment, testing what would happen to disease development if we block this single factor
OSP-C reinserted: This treatment reinserts the OSP-C factor to check if the negative strain can recover pathogenicity by only reacquiring this factor
) Answer the following questions regarding Lyme disease using data from the table below to support...
What do the results in Table 22.4 suggest about sickle-cell hemoglobin and malaria? A hemoglobin genotype in children normal (homozygous normal) mild sickling (heterozygous) B hemoglobin genotype in adult males normal (homozygous normal) mild sickling (heterozygous) percent with malaria parasite present 45.7 27.9 percent with malaria parasite present 93.3 13.3 percent with high parasite density 66.0 33.3 percent with high parasite density 40.0 0 Table 22.4. Incidence of the malaria parasite in blood of normal and sickle-cell children from a...
What do the results in Table 22.4 suggest about sickle-cell hemoglobin and malaria? A hemoglobin genotype in children normal (homozygous normal) mild sickling (heterozygous) B hemoglobin genotype in adult males normal (homozygous normal) mild sickling (heterozygous) percent with malaria parasite present 45.7 27.9 percent with malaria parasite present 93.3 percent with high parasite density 66.0 33.3 percent with high parasite density 40.0 0 13.3 Table 22.4. Incidence of the malaria parasite in blood of normal and sickle-cell children from a...